in adults with type 2 diabetes and chronic kidney disease. Ozempic is already widely used and was first FDA-approved in 2017 to treat type 2 diabetes. The medication — taken weekly by injection ...

By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.

About 40% of people with type 2 diabetes have chronic kidney disease, according to Novo Nordisk. Type 2 diabetes impacts approximately 37 million adults in the US, the company noted in a press ...

in adults with type 2 diabetes and chronic kidney disease. Ozempic is already widely used and was first FDA-approved in 2017 to treat type 2 diabetes. The medication — taken weekly by injection in the ...

The weight loss and diabetes drug making headlines has now expanded its coverage, the Food and Drug Administration has given Ozempic the green light to treat chronic kidney disease. Ozempic has gained ...

The decision could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function and is one of the leading causes of death in the U.S. Around ...

The FDA approved Ozempic to treat kidney disease in Type 2 diabetes patients ... Flood prone roads and other low lying areas may be closed due to elevated runoff and overflowing streams.